Home/Filings/5/0001415889-25-004111
5//SEC Filing

Badial Verender S. 5

Accession 0001415889-25-004111

CIK 0001855644other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 4:26 PM ET

Size

13.3 KB

Accession

0001415889-25-004111

Insider Transaction Report

Form 5
Period: 2024-12-31
Badial Verender S.
Chief Financial Officer
Transactions
  • Other

    Warrants

    2023-09-28+420,5190 total
    Exercise: $11.50From: 2023-04-19Exp: 2028-03-20Class A Ordinary Shares (420,519 underlying)
  • Disposition to Issuer

    Warrants

    2024-08-23420,5190 total
    Exercise: $11.50From: 2023-04-19Exp: 2028-03-20Class A Ordinary Shares (420,519 underlying)
  • Other

    Class A Ordinary Shares

    2023-09-22+35,484517,519 total
  • Other

    Class A Ordinary Shares

    2023-09-28+355,880517,519 total
  • Award

    Class A Ordinary Shares

    2024-08-23+126,155517,519 total
Footnotes (3)
  • [F1]The Class A ordinary shares were distributed by JATT Ventures L.P. ("JATT") to the Reporting Person for no additional consideration.
  • [F2]The reported warrants were exchanged for Class A Ordinary Shares ("Ordinary Shares") pursuant to an exchange offer from the Issuer. Each warrant holder whose warrants were exchanged pursuant to the exchange offer received 0.30 Ordinary Shares for each warrant tendered by such holder and exchanged. No fractional Ordinary Shares were issued pursuant to the exchange offer, with fractional shares paid in cash (without interest). The foregoing description of the exchange offer does not purport to be complete and is subject to, and qualified in its entirety by, the S-4 of the Issuer filed on July 12, 2024, as amended, which is incorporated herein by reference.
  • [F3]The warrants were distributed by JATT to the Reporting Person for no additional consideration.

Issuer

Zura Bio Ltd

CIK 0001855644

Entity typeother

Related Parties

1
  • filerCIK 0001870327

Filing Metadata

Form type
5
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:26 PM ET
Size
13.3 KB